Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease

This study has been terminated.
(Lack of recruitment)
Amylin Pharmaceuticals, LLC.
Eli Lilly and Company
Information provided by (Responsible Party):
Christopher Bowlus, MD, University of California, Davis Identifier:
First received: September 12, 2007
Last updated: May 19, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2010
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)